Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tralokinumab in uncontrolled, severe asthma
NCT01402986Phase 2Completed
- Sponsor
- MedImmune
- Start
- Aug 2011
- Primary completion
- Jun 2013
- Modality
- Monoclonal Antibodies
- Countries
- 15
01
Overview
A Phase 2 trial of tralokinumab in asthma, sponsored by MedImmune. Started Aug 2011; status: completed.
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01402986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402986.